

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * B cell receptor signaling pathway (GO:0050853) | 8.52840287 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.36027878 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.32192838 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.98883216 |
| 5 | regulation of B cell differentiation (GO:0045577) | 6.27567486 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.00097516 |
| 7 | B cell proliferation (GO:0042100) | 5.80612270 |
| 8 | positive regulation of B cell differentiation (GO:0045579) | 5.78034880 |
| 9 | cellular response to zinc ion (GO:0071294) | 5.77513918 |
| 10 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.51019662 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 5.49426022 |
| 12 | positive thymic T cell selection (GO:0045059) | 5.47322950 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 5.47274845 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.46303531 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.46303531 |
| 16 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 5.23336054 |
| 17 | response to interleukin-15 (GO:0070672) | 5.13063620 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.71367498 |
| 19 | mature B cell differentiation (GO:0002335) | 4.69197299 |
| 20 | negative regulation of cell killing (GO:0031342) | 4.46032672 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.46032672 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.43611060 |
| 23 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.39653971 |
| 24 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.39064566 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 4.37293612 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 4.37293612 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.37293612 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.37293612 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.37293612 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 4.37293612 |
| 31 | detection of bacterium (GO:0016045) | 4.35073277 |
| 32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.34534135 |
| 33 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.30570606 |
| 34 | regulation of B cell proliferation (GO:0030888) | 4.27222490 |
| 35 | regulation of antigen processing and presentation (GO:0002577) | 4.23483476 |
| 36 | negative regulation of B cell proliferation (GO:0030889) | 4.15121258 |
| 37 | detection of other organism (GO:0098543) | 4.08249096 |
| 38 | thymic T cell selection (GO:0045061) | 4.04418474 |
| 39 | regulation of B cell apoptotic process (GO:0002902) | 3.98936283 |
| 40 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.91167826 |
| 41 | T cell selection (GO:0045058) | 3.90112421 |
| 42 | lymph node development (GO:0048535) | 3.90098092 |
| 43 | B cell activation (GO:0042113) | 3.88633013 |
| 44 | positive T cell selection (GO:0043368) | 3.86127411 |
| 45 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.82576012 |
| 46 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.82378212 |
| 47 | response to type I interferon (GO:0034340) | 3.80693731 |
| 48 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.80287866 |
| 49 | cellular response to type I interferon (GO:0071357) | 3.79796910 |
| 50 | type I interferon signaling pathway (GO:0060337) | 3.79796910 |
| 51 | B cell mediated immunity (GO:0019724) | 3.77500722 |
| 52 | negative thymic T cell selection (GO:0045060) | 3.76832535 |
| 53 | negative regulation of phagocytosis (GO:0050765) | 3.76452680 |
| 54 | defense response to protozoan (GO:0042832) | 3.73217288 |
| 55 | T cell lineage commitment (GO:0002360) | 3.72069947 |
| 56 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.71778819 |
| 57 | lymphocyte homeostasis (GO:0002260) | 3.70558275 |
| 58 | negative regulation of histone methylation (GO:0031061) | 3.69094301 |
| 59 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.68857816 |
| 60 | B cell homeostasis (GO:0001782) | 3.66420663 |
| 61 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.66315318 |
| 62 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.61586748 |
| 63 | regulation of superoxide anion generation (GO:0032928) | 3.61515908 |
| 64 | positive regulation of humoral immune response (GO:0002922) | 3.57043300 |
| 65 | T cell costimulation (GO:0031295) | 3.56923465 |
| 66 | positive regulation of B cell proliferation (GO:0030890) | 3.54968979 |
| 67 | tolerance induction (GO:0002507) | 3.49635895 |
| 68 | lymphocyte costimulation (GO:0031294) | 3.48789333 |
| 69 | negative T cell selection (GO:0043383) | 3.48190715 |
| 70 | neutrophil activation (GO:0042119) | 3.46870131 |
| 71 | positive regulation of Rap GTPase activity (GO:0032854) | 3.45253727 |
| 72 | lymphocyte proliferation (GO:0046651) | 3.44789529 |
| 73 | mononuclear cell proliferation (GO:0032943) | 3.44666481 |
| 74 | T cell homeostasis (GO:0043029) | 3.41973913 |
| 75 | negative regulation of B cell apoptotic process (GO:0002903) | 3.41895814 |
| 76 | serine transport (GO:0032329) | 3.41768641 |
| 77 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.40393555 |
| 78 | positive regulation of histone deacetylation (GO:0031065) | 3.38017536 |
| 79 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.37976895 |
| 80 | mature B cell differentiation involved in immune response (GO:0002313) | 3.37932870 |
| 81 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.36968465 |
| 82 | negative regulation of bone resorption (GO:0045779) | 3.36689280 |
| 83 | positive regulation of B cell activation (GO:0050871) | 3.33678655 |
| 84 | regulation of B cell activation (GO:0050864) | 3.31670720 |
| 85 | positive regulation of interferon-alpha production (GO:0032727) | 3.30813588 |
| 86 | NIK/NF-kappaB signaling (GO:0038061) | 3.26650528 |
| 87 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.24541031 |
| 88 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.24541031 |
| 89 | T cell migration (GO:0072678) | 3.23560895 |
| 90 | B cell differentiation (GO:0030183) | 3.22544529 |
| 91 | regulation of histone H3-K9 methylation (GO:0051570) | 3.22442720 |
| 92 | response to muramyl dipeptide (GO:0032495) | 3.21224209 |
| 93 | positive regulation of interleukin-2 production (GO:0032743) | 3.21202110 |
| 94 | immunoglobulin mediated immune response (GO:0016064) | 3.20581402 |
| 95 | positive regulation of type 2 immune response (GO:0002830) | 3.20268754 |
| 96 | leukocyte aggregation (GO:0070486) | 3.19232504 |
| 97 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.18568892 |
| 98 | leukocyte homeostasis (GO:0001776) | 3.18503983 |
| 99 | positive regulation of immunoglobulin production (GO:0002639) | 3.17387045 |
| 100 | detection of external biotic stimulus (GO:0098581) | 3.14289305 |
| 101 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.14058053 |
| 102 | response to protozoan (GO:0001562) | 3.13797667 |
| 103 | histone H3-K36 demethylation (GO:0070544) | 3.12878527 |
| 104 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.12744251 |
| 105 | regulation of interferon-alpha production (GO:0032647) | 3.12172304 |
| 106 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12021335 |
| 107 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.11362849 |
| 108 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.11362849 |
| 109 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.11362849 |
| 110 | germinal center formation (GO:0002467) | 3.08358821 |
| 111 | leukocyte proliferation (GO:0070661) | 3.07546456 |
| 112 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.07354482 |
| 113 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.06288540 |
| 114 | granulocyte activation (GO:0036230) | 3.05619283 |
| 115 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.03025113 |
| 116 | positive regulation of granulocyte differentiation (GO:0030854) | 3.02822780 |
| 117 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00699113 |
| 118 | cytidine deamination (GO:0009972) | 3.00628438 |
| 119 | cytidine metabolic process (GO:0046087) | 3.00628438 |
| 120 | cytidine catabolic process (GO:0006216) | 3.00628438 |
| 121 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.99911489 |
| 122 | macrophage activation involved in immune response (GO:0002281) | 2.96969099 |
| 123 | T-helper 1 type immune response (GO:0042088) | 2.96864692 |
| 124 | respiratory burst (GO:0045730) | 2.94521468 |
| 125 | cellular response to interferon-gamma (GO:0071346) | 2.94073003 |
| 126 | hepatocyte apoptotic process (GO:0097284) | 2.91613801 |
| 127 | T cell receptor signaling pathway (GO:0050852) | 2.91534738 |
| 128 | response to host immune response (GO:0052572) | 2.90957877 |
| 129 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.90957877 |
| 130 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.90837521 |
| 131 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.89483224 |
| 132 | positive regulation of B cell mediated immunity (GO:0002714) | 2.89483224 |
| 133 | positive regulation of antigen processing and presentation (GO:0002579) | 2.88038975 |
| 134 | regulation of germinal center formation (GO:0002634) | 2.87459749 |
| 135 | negative regulation of T cell mediated immunity (GO:0002710) | 2.87347500 |
| 136 | activation of JUN kinase activity (GO:0007257) | 2.87114531 |
| 137 | natural killer cell differentiation (GO:0001779) | 2.86686564 |
| 138 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.83583617 |
| 139 | * immune response-activating signal transduction (GO:0002757) | 2.81537513 |
| 140 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.81414048 |
| 141 | regulation of Rap GTPase activity (GO:0032317) | 2.80892162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.73351105 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 5.09421900 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.66850745 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.50081846 |
| 5 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.15638274 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.70024155 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.67770451 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.66137130 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.54552373 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13483591 |
| 11 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.08027614 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.89325512 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.78683519 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.76993608 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.72098433 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.64200916 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.59877935 |
| 18 | * MYB_26560356_Chip-Seq_TH2_Human | 2.55833722 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.51552784 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.33224040 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.24028441 |
| 22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.23869178 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.22814623 |
| 24 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.21429337 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.16518941 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12274381 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.12262093 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10310104 |
| 29 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08686980 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.06800884 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04203335 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.02516507 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01646819 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00448540 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.98279818 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.90818508 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.90076552 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.87961032 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.80587902 |
| 40 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.79979346 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78774089 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76308250 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.71869225 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.70935392 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67574133 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67362260 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66923553 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63087566 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56482173 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54705382 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51807659 |
| 52 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.49749938 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.46995270 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44313237 |
| 55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44196990 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43340460 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41585974 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41450045 |
| 59 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.41416362 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39623236 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26137768 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22384016 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21947863 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19228369 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17539203 |
| 66 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15503032 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12412948 |
| 68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.12038786 |
| 69 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.11230020 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06626999 |
| 71 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06314312 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06073417 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.05367890 |
| 74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04679272 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03983880 |
| 76 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.02434770 |
| 77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02231186 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02151258 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02017934 |
| 80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.00113478 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97493456 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95414511 |
| 83 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94655557 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93268837 |
| 85 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92393272 |
| 86 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.92034367 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91497088 |
| 88 | P300_27268052_Chip-Seq_Bcells_Human | 0.91184168 |
| 89 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.89851309 |
| 90 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89329110 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88464652 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86580980 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84693348 |
| 94 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84445885 |
| 95 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.84437148 |
| 96 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83205445 |
| 97 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82926844 |
| 98 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.82763535 |
| 99 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.81827622 |
| 100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80589354 |
| 101 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.79646621 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79345174 |
| 103 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79259403 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78206478 |
| 105 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.77038306 |
| 106 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77013314 |
| 107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74770984 |
| 108 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.73862557 |
| 109 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.73665314 |
| 110 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.73404473 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73204776 |
| 112 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.72895864 |
| 113 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72437859 |
| 114 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.71153587 |
| 115 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70207691 |
| 116 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.69997268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.59241638 |
| 2 | MP0001800_abnormal_humoral_immune | 5.04773858 |
| 3 | MP0005387_immune_system_phenotype | 4.98458179 |
| 4 | MP0001790_abnormal_immune_system | 4.98458179 |
| 5 | MP0000685_abnormal_immune_system | 4.40448207 |
| 6 | MP0002452_abnormal_antigen_presenting | 3.76734285 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.43837401 |
| 8 | MP0003303_peritoneal_inflammation | 3.34882201 |
| 9 | MP0002723_abnormal_immune_serum | 3.20983714 |
| 10 | MP0005671_abnormal_response_to | 3.18273285 |
| 11 | MP0002420_abnormal_adaptive_immunity | 3.17292348 |
| 12 | MP0001819_abnormal_immune_cell | 3.06304630 |
| 13 | * MP0002398_abnormal_bone_marrow | 3.02165623 |
| 14 | * MP0000716_abnormal_immune_system | 2.74692424 |
| 15 | MP0000689_abnormal_spleen_morphology | 2.73660450 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.68459740 |
| 17 | MP0002722_abnormal_immune_system | 2.33868161 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.31985979 |
| 19 | * MP0002429_abnormal_blood_cell | 2.24596248 |
| 20 | MP0005025_abnormal_response_to | 2.13080414 |
| 21 | MP0001873_stomach_inflammation | 2.09339712 |
| 22 | MP0002396_abnormal_hematopoietic_system | 2.08222231 |
| 23 | MP0004510_myositis | 2.05879926 |
| 24 | MP0009785_altered_susceptibility_to | 2.05671539 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.89777297 |
| 26 | MP0002419_abnormal_innate_immunity | 1.87889238 |
| 27 | MP0002405_respiratory_system_inflammati | 1.84622219 |
| 28 | MP0000703_abnormal_thymus_morphology | 1.78628741 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.69900352 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.69226597 |
| 31 | MP0003436_decreased_susceptibility_to | 1.67909888 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.67556957 |
| 33 | MP0003724_increased_susceptibility_to | 1.66140126 |
| 34 | MP0001853_heart_inflammation | 1.61820683 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.60535735 |
| 36 | MP0004381_abnormal_hair_follicle | 1.58808668 |
| 37 | MP0004947_skin_inflammation | 1.58102884 |
| 38 | MP0001348_abnormal_lacrimal_gland | 1.55303485 |
| 39 | MP0002006_tumorigenesis | 1.53642787 |
| 40 | MP0003866_abnormal_defecation | 1.51340657 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.50911248 |
| 42 | MP0008057_abnormal_DNA_replication | 1.48945682 |
| 43 | MP0002933_joint_inflammation | 1.47334021 |
| 44 | MP0005310_abnormal_salivary_gland | 1.35247061 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.33517310 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.30517141 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.29886199 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.27998593 |
| 49 | MP0008260_abnormal_autophagy | 1.26655790 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.20480319 |
| 51 | MP0002019_abnormal_tumor_incidence | 1.12643709 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.05780560 |
| 53 | MP0006054_spinal_hemorrhage | 1.02460494 |
| 54 | MP0002136_abnormal_kidney_physiology | 1.02012805 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.00116285 |
| 56 | MP0001879_abnormal_lymphatic_vessel | 0.99030544 |
| 57 | MP0002132_abnormal_respiratory_system | 0.96607082 |
| 58 | MP0003077_abnormal_cell_cycle | 0.95965022 |
| 59 | MP0002909_abnormal_adrenal_gland | 0.95017736 |
| 60 | MP0008469_abnormal_protein_level | 0.94524635 |
| 61 | MP0010094_abnormal_chromosome_stability | 0.92543061 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 0.90524276 |
| 63 | MP0000015_abnormal_ear_pigmentation | 0.85434209 |
| 64 | MP0003091_abnormal_cell_migration | 0.85229292 |
| 65 | MP0002928_abnormal_bile_duct | 0.85068517 |
| 66 | MP0001986_abnormal_taste_sensitivity | 0.83163351 |
| 67 | MP0008961_abnormal_basal_metabolism | 0.82841615 |
| 68 | MP0003787_abnormal_imprinting | 0.82739605 |
| 69 | MP0002095_abnormal_skin_pigmentation | 0.82399122 |
| 70 | MP0003045_fibrosis | 0.81906766 |
| 71 | MP0000858_altered_metastatic_potential | 0.78252547 |
| 72 | MP0008874_decreased_physiological_sensi | 0.74510028 |
| 73 | MP0005076_abnormal_cell_differentiation | 0.73098304 |
| 74 | MP0002009_preneoplasia | 0.70128174 |
| 75 | MP0009278_abnormal_bone_marrow | 0.69692584 |
| 76 | MP0000372_irregular_coat_pigmentation | 0.68742638 |
| 77 | MP0002163_abnormal_gland_morphology | 0.68722068 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.63917418 |
| 79 | MP0002998_abnormal_bone_remodeling | 0.62383196 |
| 80 | MP0000249_abnormal_blood_vessel | 0.60420486 |
| 81 | MP0000350_abnormal_cell_proliferation | 0.60307903 |
| 82 | MP0009764_decreased_sensitivity_to | 0.59670804 |
| 83 | MP0000490_abnormal_crypts_of | 0.59266064 |
| 84 | MP0001851_eye_inflammation | 0.56843717 |
| 85 | MP0003111_abnormal_nucleus_morphology | 0.56030680 |
| 86 | MP0004883_abnormal_blood_vessel | 0.55990721 |
| 87 | MP0005621_abnormal_cell_physiology | 0.54980047 |
| 88 | MP0003191_abnormal_cellular_cholesterol | 0.53939630 |
| 89 | MP0000767_abnormal_smooth_muscle | 0.53732894 |
| 90 | MP0001663_abnormal_digestive_system | 0.52632242 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.52478856 |
| 92 | MP0000313_abnormal_cell_death | 0.52299008 |
| 93 | MP0005397_hematopoietic_system_phenotyp | 0.51801550 |
| 94 | MP0001545_abnormal_hematopoietic_system | 0.51801550 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.51552028 |
| 96 | MP0005166_decreased_susceptibility_to | 0.49426672 |
| 97 | MP0001533_abnormal_skeleton_physiology | 0.49365867 |
| 98 | MP0003693_abnormal_embryo_hatching | 0.48624148 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.47568215 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.47499071 |
| 101 | MP0006082_CNS_inflammation | 0.47203700 |
| 102 | MP0005451_abnormal_body_composition | 0.46848587 |
| 103 | MP0005381_digestive/alimentary_phenotyp | 0.46689013 |
| 104 | MP0002693_abnormal_pancreas_physiology | 0.46616204 |
| 105 | MP0009115_abnormal_fat_cell | 0.46408689 |
| 106 | MP0003828_pulmonary_edema | 0.46406556 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.45292830 |
| 108 | MP0009763_increased_sensitivity_to | 0.45050471 |
| 109 | MP0002083_premature_death | 0.44134027 |
| 110 | MP0001730_embryonic_growth_arrest | 0.43842154 |
| 111 | MP0002168_other_aberrant_phenotype | 0.42689659 |
| 112 | MP0000609_abnormal_liver_physiology | 0.42209314 |
| 113 | MP0005379_endocrine/exocrine_gland_phen | 0.40001972 |
| 114 | MP0000371_diluted_coat_color | 0.39095660 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.37971650 |
| 116 | MP0010630_abnormal_cardiac_muscle | 0.37707628 |
| 117 | MP0001784_abnormal_fluid_regulation | 0.37320893 |
| 118 | MP0002135_abnormal_kidney_morphology | 0.37152053 |
| 119 | MP0000477_abnormal_intestine_morphology | 0.36926883 |
| 120 | MP0005075_abnormal_melanosome_morpholog | 0.36739967 |
| 121 | MP0003252_abnormal_bile_duct | 0.35413590 |
| 122 | MP0005384_cellular_phenotype | 0.34666128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.59512213 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 7.89721242 |
| 3 | Recurrent bronchitis (HP:0002837) | 6.78257885 |
| 4 | Cellulitis (HP:0100658) | 6.29390197 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.10451789 |
| 6 | Papilloma (HP:0012740) | 5.90997550 |
| 7 | Verrucae (HP:0200043) | 5.90997550 |
| 8 | Colitis (HP:0002583) | 5.69414166 |
| 9 | IgM deficiency (HP:0002850) | 5.53965312 |
| 10 | Lymphopenia (HP:0001888) | 5.10639021 |
| 11 | Inflammation of the large intestine (HP:0002037) | 4.91064785 |
| 12 | Emphysema (HP:0002097) | 4.87600173 |
| 13 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.86137067 |
| 14 | Gastrointestinal inflammation (HP:0004386) | 4.74484362 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 4.74374759 |
| 16 | Recurrent viral infections (HP:0004429) | 4.72584293 |
| 17 | Meningitis (HP:0001287) | 4.64677548 |
| 18 | Chronic sinusitis (HP:0011109) | 4.51459441 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.43981006 |
| 20 | IgA deficiency (HP:0002720) | 4.24416555 |
| 21 | Abnormality of B cell number (HP:0010975) | 4.20062585 |
| 22 | B lymphocytopenia (HP:0010976) | 4.20062585 |
| 23 | Thyroiditis (HP:0100646) | 4.18425847 |
| 24 | Small epiphyses (HP:0010585) | 4.18004649 |
| 25 | Vasculitis (HP:0002633) | 4.06694303 |
| 26 | Recurrent otitis media (HP:0000403) | 3.96639750 |
| 27 | Chronic otitis media (HP:0000389) | 3.93071608 |
| 28 | Bronchitis (HP:0012387) | 3.85010034 |
| 29 | Osteomyelitis (HP:0002754) | 3.83871294 |
| 30 | Recurrent pneumonia (HP:0006532) | 3.83692969 |
| 31 | Restrictive lung disease (HP:0002091) | 3.79353704 |
| 32 | Recurrent lower respiratory tract infections (HP:0002783) | 3.66665612 |
| 33 | Sepsis (HP:0100806) | 3.43347243 |
| 34 | Recurrent fungal infections (HP:0002841) | 3.42396504 |
| 35 | IgG deficiency (HP:0004315) | 3.39117982 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 3.38658368 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.38658368 |
| 38 | Abnormality of macrophages (HP:0004311) | 3.25310407 |
| 39 | Chronic diarrhea (HP:0002028) | 3.22255798 |
| 40 | Mitral stenosis (HP:0001718) | 3.21192703 |
| 41 | T lymphocytopenia (HP:0005403) | 3.18006026 |
| 42 | Abnormality of T cells (HP:0002843) | 3.17100219 |
| 43 | Recurrent abscess formation (HP:0002722) | 3.16084851 |
| 44 | Recurrent bacterial skin infections (HP:0005406) | 3.08203425 |
| 45 | Abnormality of T cell number (HP:0011839) | 3.05526323 |
| 46 | Vertebral arch anomaly (HP:0008438) | 3.02277014 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 3.02038835 |
| 48 | Abnormality of the fingertips (HP:0001211) | 2.93286137 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 2.91633161 |
| 50 | Lymphoma (HP:0002665) | 2.89659563 |
| 51 | Abnormality of the prostate (HP:0008775) | 2.84154260 |
| 52 | Viral hepatitis (HP:0006562) | 2.83284341 |
| 53 | Leukopenia (HP:0001882) | 2.78651236 |
| 54 | Recurrent skin infections (HP:0001581) | 2.77519857 |
| 55 | Gastrointestinal infarctions (HP:0005244) | 2.76210036 |
| 56 | Combined immunodeficiency (HP:0005387) | 2.71111618 |
| 57 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.64741260 |
| 58 | Flattened epiphyses (HP:0003071) | 2.61020629 |
| 59 | Severe combined immunodeficiency (HP:0004430) | 2.60772729 |
| 60 | Urticaria (HP:0001025) | 2.51652509 |
| 61 | Retrobulbar optic neuritis (HP:0100654) | 2.51550092 |
| 62 | Optic neuritis (HP:0100653) | 2.51550092 |
| 63 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.39165216 |
| 64 | Skin rash (HP:0000988) | 2.36460686 |
| 65 | Eczematoid dermatitis (HP:0000976) | 2.34872790 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.30401760 |
| 67 | Nasal polyposis (HP:0100582) | 2.29754664 |
| 68 | Irregular vertebral endplates (HP:0003301) | 2.29154113 |
| 69 | Orchitis (HP:0100796) | 2.28684657 |
| 70 | Abnormality of the pleura (HP:0002103) | 2.25204387 |
| 71 | Pustule (HP:0200039) | 2.23853644 |
| 72 | Skin ulcer (HP:0200042) | 2.23252513 |
| 73 | Encephalitis (HP:0002383) | 2.21929859 |
| 74 | Neutropenia (HP:0001875) | 2.21483110 |
| 75 | Pulmonary infiltrates (HP:0002113) | 2.19444066 |
| 76 | Thrombocytosis (HP:0001894) | 2.17865521 |
| 77 | Abnormality of the peritoneum (HP:0002585) | 2.13387609 |
| 78 | Increased IgM level (HP:0003496) | 2.13226905 |
| 79 | Obstructive lung disease (HP:0006536) | 2.11338980 |
| 80 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11338980 |
| 81 | Ulnar bowing (HP:0003031) | 2.10951393 |
| 82 | Absent epiphyses (HP:0010577) | 2.08132771 |
| 83 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.08132771 |
| 84 | Prolonged bleeding time (HP:0003010) | 2.08097072 |
| 85 | Interstitial pulmonary disease (HP:0006530) | 2.06957989 |
| 86 | Abnormality of the intervertebral disk (HP:0005108) | 2.05914398 |
| 87 | Hemoptysis (HP:0002105) | 2.05569370 |
| 88 | Abnormality of male internal genitalia (HP:0000022) | 2.01830996 |
| 89 | Arthralgia (HP:0002829) | 2.00375772 |
| 90 | Epistaxis (HP:0000421) | 1.97891269 |
| 91 | Granulocytopenia (HP:0001913) | 1.97229218 |
| 92 | Gingivitis (HP:0000230) | 1.96192074 |
| 93 | Spontaneous hematomas (HP:0007420) | 1.96010348 |
| 94 | Increased IgE level (HP:0003212) | 1.95716109 |
| 95 | Hypoplasia of the thymus (HP:0000778) | 1.93266337 |
| 96 | Arthropathy (HP:0003040) | 1.91414331 |
| 97 | Basal cell carcinoma (HP:0002671) | 1.88711989 |
| 98 | Pulmonary fibrosis (HP:0002206) | 1.88357110 |
| 99 | Pulmonary embolism (HP:0002204) | 1.86828627 |
| 100 | Abnormality of the nasal mucosa (HP:0000433) | 1.85868467 |
| 101 | Teleangiectasia of the skin (HP:0100585) | 1.84926355 |
| 102 | Hematochezia (HP:0002573) | 1.83238502 |
| 103 | Xerostomia (HP:0000217) | 1.81291937 |
| 104 | Premature loss of primary teeth (HP:0006323) | 1.80940100 |
| 105 | Slow saccadic eye movements (HP:0000514) | 1.79412054 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 1.79349804 |
| 107 | Keratoconjunctivitis sicca (HP:0001097) | 1.78692705 |
| 108 | Autoimmune hemolytic anemia (HP:0001890) | 1.78158172 |
| 109 | Deep palmar crease (HP:0006191) | 1.77063167 |
| 110 | Hepatitis (HP:0012115) | 1.75814739 |
| 111 | Abnormality of eosinophils (HP:0001879) | 1.72855492 |
| 112 | Barrel-shaped chest (HP:0001552) | 1.72568847 |
| 113 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.71392185 |
| 114 | Acrocyanosis (HP:0001063) | 1.70464851 |
| 115 | Abnormality of the vertebral endplates (HP:0005106) | 1.67964030 |
| 116 | Fatigue (HP:0012378) | 1.67485408 |
| 117 | Limited elbow extension (HP:0001377) | 1.66287239 |
| 118 | Papilledema (HP:0001085) | 1.64298494 |
| 119 | Chest pain (HP:0100749) | 1.61039341 |
| 120 | Eosinophilia (HP:0001880) | 1.59027212 |
| 121 | Myositis (HP:0100614) | 1.57831465 |
| 122 | Facial diplegia (HP:0001349) | 1.56497818 |
| 123 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.53667509 |
| 124 | Hypertensive crisis (HP:0100735) | 1.52107483 |
| 125 | Villous atrophy (HP:0011473) | 1.50652993 |
| 126 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.50652993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 7.19311944 |
| 2 | MAP3K10 | 4.41697896 |
| 3 | GRK6 | 3.90642674 |
| 4 | ERN1 | 3.60550649 |
| 5 | PRPF4B | 3.28268397 |
| 6 | BLK | 3.07186464 |
| 7 | CSF1R | 2.89179621 |
| 8 | SYK | 2.75849217 |
| 9 | BTK | 2.46016636 |
| 10 | MAP3K13 | 2.33094897 |
| 11 | JAK1 | 2.30870785 |
| 12 | RIPK4 | 2.27477894 |
| 13 | LRRK2 | 2.25787067 |
| 14 | STK10 | 2.16514474 |
| 15 | SIK2 | 2.14955109 |
| 16 | MAP3K14 | 1.90769342 |
| 17 | EEF2K | 1.80504781 |
| 18 | TYK2 | 1.70085311 |
| 19 | PASK | 1.65618500 |
| 20 | BMPR2 | 1.65169243 |
| 21 | LYN | 1.59919471 |
| 22 | CDK12 | 1.59358998 |
| 23 | SMG1 | 1.48150318 |
| 24 | EIF2AK3 | 1.45820864 |
| 25 | ZAP70 | 1.42733190 |
| 26 | CSK | 1.29966895 |
| 27 | MST4 | 1.29082259 |
| 28 | ITK | 1.23269164 |
| 29 | GRK1 | 1.20331825 |
| 30 | TBK1 | 1.18669933 |
| 31 | MARK3 | 1.18231369 |
| 32 | NME2 | 1.17441452 |
| 33 | IRAK3 | 1.17085289 |
| 34 | SIK3 | 1.15351430 |
| 35 | TXK | 1.14288814 |
| 36 | IKBKB | 1.13098314 |
| 37 | CLK1 | 1.12926043 |
| 38 | KIT | 1.12116993 |
| 39 | TEC | 1.09464288 |
| 40 | NEK9 | 1.08330121 |
| 41 | SIK1 | 1.06149854 |
| 42 | PIM1 | 1.02100361 |
| 43 | FES | 1.01780544 |
| 44 | JAK3 | 1.00690969 |
| 45 | LCK | 0.99987404 |
| 46 | PRKCQ | 0.96468156 |
| 47 | TNK2 | 0.94669385 |
| 48 | IRAK4 | 0.94275346 |
| 49 | TRIB3 | 0.90815669 |
| 50 | BRD4 | 0.90638857 |
| 51 | * HCK | 0.88202636 |
| 52 | SCYL2 | 0.86286014 |
| 53 | TLK1 | 0.84494641 |
| 54 | CDK19 | 0.82653616 |
| 55 | PRKCH | 0.78916697 |
| 56 | TESK2 | 0.78627664 |
| 57 | NEK2 | 0.77118300 |
| 58 | CDC42BPA | 0.76677390 |
| 59 | CDK4 | 0.76435996 |
| 60 | HIPK2 | 0.75770533 |
| 61 | STK4 | 0.75073944 |
| 62 | TGFBR2 | 0.75038876 |
| 63 | FGFR3 | 0.73678102 |
| 64 | IKBKE | 0.72698179 |
| 65 | ALK | 0.72450352 |
| 66 | IRAK2 | 0.71972999 |
| 67 | MATK | 0.71081404 |
| 68 | PRKD2 | 0.70245674 |
| 69 | CDK9 | 0.64786189 |
| 70 | MAP3K7 | 0.63428116 |
| 71 | MAPK7 | 0.61764315 |
| 72 | MELK | 0.59679090 |
| 73 | CHUK | 0.59073990 |
| 74 | PKN2 | 0.58785110 |
| 75 | MAPK12 | 0.58639651 |
| 76 | FGFR4 | 0.57984373 |
| 77 | EIF2AK1 | 0.55791657 |
| 78 | PDK1 | 0.55568204 |
| 79 | PDPK1 | 0.53133501 |
| 80 | PRKD1 | 0.52609692 |
| 81 | ABL1 | 0.52050811 |
| 82 | INSR | 0.51017797 |
| 83 | DYRK1B | 0.50903272 |
| 84 | KDR | 0.48817862 |
| 85 | IRAK1 | 0.48154708 |
| 86 | MAP3K1 | 0.48085581 |
| 87 | CAMKK1 | 0.48047699 |
| 88 | RPS6KA4 | 0.47471798 |
| 89 | FYN | 0.45736853 |
| 90 | MAP2K2 | 0.45340769 |
| 91 | WNK1 | 0.45003707 |
| 92 | KSR2 | 0.44003150 |
| 93 | TAOK2 | 0.42336073 |
| 94 | TAOK3 | 0.38759652 |
| 95 | MAP2K3 | 0.38423178 |
| 96 | MAP3K8 | 0.38133228 |
| 97 | ICK | 0.37825289 |
| 98 | YES1 | 0.35953442 |
| 99 | MAP3K11 | 0.33495239 |
| 100 | TAOK1 | 0.33115885 |
| 101 | FGR | 0.32443291 |
| 102 | MAPK4 | 0.32163261 |
| 103 | NLK | 0.32097321 |
| 104 | MAPKAPK2 | 0.31789042 |
| 105 | STK24 | 0.31145382 |
| 106 | RPS6KB2 | 0.30472615 |
| 107 | PRKCD | 0.29767808 |
| 108 | CAMK1G | 0.28608631 |
| 109 | JAK2 | 0.28251134 |
| 110 | EGFR | 0.27655912 |
| 111 | MARK2 | 0.26666203 |
| 112 | SGK2 | 0.25592745 |
| 113 | SGK3 | 0.25033087 |
| 114 | MAPK11 | 0.24430186 |
| 115 | FRK | 0.24299701 |
| 116 | CSNK1D | 0.24280649 |
| 117 | PTK6 | 0.23295120 |
| 118 | STK11 | 0.23001599 |
| 119 | CSNK1A1L | 0.22631975 |
| 120 | CHEK1 | 0.21999743 |
| 121 | CCNB1 | 0.21367915 |
| 122 | MAP3K9 | 0.20149179 |
| 123 | MAPK3 | 0.18776255 |
| 124 | CAMK1D | 0.18027053 |
| 125 | ATR | 0.17822605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.93319960 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 6.32002308 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.98311442 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.81397458 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.76194823 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.43757101 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.20795478 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.98906418 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.93354963 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.35008362 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.24629789 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17371286 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.15609699 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.09287360 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.90690776 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.89339184 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.69037370 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.58862881 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.58639863 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.56750983 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.56490748 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53023683 |
| 23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.51922441 |
| 24 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.35847328 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.28783610 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27065628 |
| 27 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.25235063 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22487935 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19411841 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18980547 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17651453 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12257558 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09665030 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09008367 |
| 35 | Ribosome_Homo sapiens_hsa03010 | 1.08775912 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.07064317 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.06160586 |
| 38 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.04249778 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.03976408 |
| 40 | Mismatch repair_Homo sapiens_hsa03430 | 1.03477691 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02553509 |
| 42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99752612 |
| 43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98393165 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97864663 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 0.97484651 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96710741 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.94925073 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93305659 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92199742 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88990304 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85586537 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.83406134 |
| 53 | DNA replication_Homo sapiens_hsa03030 | 0.83282797 |
| 54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79220756 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77364729 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74687461 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.72991959 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72507660 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70329420 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69143568 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.63765811 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 0.63347642 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.61345881 |
| 64 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60426843 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58719209 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58306642 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.57934844 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57499590 |
| 69 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57303183 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56752203 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56544308 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56250223 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.56226804 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54847795 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.52729253 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51339268 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46124131 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.44773220 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44547089 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.44236612 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44106154 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42807209 |
| 83 | Homologous recombination_Homo sapiens_hsa03440 | 0.41770179 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41401261 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40550569 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38910571 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37943685 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.36028169 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36010894 |
| 90 | Alcoholism_Homo sapiens_hsa05034 | 0.35689273 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.34944351 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.34230029 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.33960503 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.33802114 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32232201 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31422323 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31224236 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30912522 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30737467 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28673821 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27471767 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25486483 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23467982 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22567602 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21617226 |
| 106 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.21543885 |
| 107 | Long-term potentiation_Homo sapiens_hsa04720 | 0.21532017 |
| 108 | RNA degradation_Homo sapiens_hsa03018 | 0.21226947 |
| 109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.20777616 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20030777 |
| 111 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.19538111 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19440721 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19041114 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.18261087 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.17911016 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17779379 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.16710050 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.13708471 |
| 119 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.13667237 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.12966316 |

